ISSN: 2381-8727

International Journal of Inflammation, Cancer and Integrative Therapy
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Rapid Communication   
  • Int J Inflam Cancer Integr Ther 2024, Vol 12(1): 328

Targeting NLRP3 Inflammasome Pathway in Cancer: A Novel Therapeutic Strategy

Takeshi Hojoa*
Department of Biotechnology and Drug Discovery, Okayama University, Japan
*Corresponding Author : Takeshi Hojoa, Department of Biotechnology and Drug Discovery, Okayama University, Japan, Email: takhojoa@ncc.go.jp

Received Date: Feb 01, 2025 / Published Date: Feb 27, 2025

Citation: Takeshi H (2025) Targeting NLRP3 Inflammasome Pathway in Cancer: ANovel Therapeutic Strategy. Int J Inflam Cancer Integr Ther, 12: 328.

Copyright: © 2025 Takeshi H. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top